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Abstract 
Obesity is a common public health problem
and obese individuals in particular have a dis-
proportionate  incidence  of  acute  coronary
events. This study was undertaken to identify
coronary artery lesions as well as associated
clinical features, risk factors and demograph-
ics in patients with a body mass index (BMI)
>40 kg/m2 without known coronary artery dis-
ease  (CAD).  Morbidly  obese  subjects  were
prospectively  recruited  to  undergo  coronary
computed  tomographic  angiography  (CCTA)
using  a  dual-source  computed  tomography
(CT) system. CAD was defined as the presence
of any atherosclerotic lesion in any one coro-
nary artery segment. The presence, location,
and severity of atherosclerosis were related to
patient characteristics. Forty-one patients (28
women,  mean  age,  50.4±10.0  years,  mean
BMI, 43.8±4.8 kg/m
2) served as the study pop-
ulation. Of these, 25 patients (61%) had at
least one coronary stenosis. All but 2 patients
within the CAD cohort had coronary artery cal-
cium (CAC) scores >0, and most plaques iden-
tified (75.4%) were non-calcified. There was a
predilection of calcified and non-calcified ath-
erosclerosis  involving  the  left  anterior
descending (LAD) coronary artery compared
with other coronary segments. Univariate pre-
dictors  of  CAD  included  older  age,  dyslipi-
demia, and diabetes. In this preliminary study
of  young  morbidly  obese  patients,  CCTA
detected  a  high  prevalence  of  calcified  and
non-calcified CAD, although the later predom-
inated.
Introduction
Obesity is a common public health problem
reaching  epidemic  proportions  in  recent
decades.  In the United States, 66% of adults
are overweight and nearly half of these are
obese defined as having a body mass index
(BMI) >30 kg/m
2.
1 Obesity is now classified as
an independent modifiable risk factor for the
development of coronary artery disease (CAD)
and  morbidly  obese  individuals  (BMI  >40
kg/m
2) in particular have a disproportionate
incidence of acute coronary events.
2,3In a large
retrospective analysis of 111,847 patients in
the CRUSADE registry, we reported that BMI
>40 kg/m
2 is the strongest determinant of first
non-ST-segment elevation myocardial infarc-
tion  occurring  prematurely,  exceeding  the
impact  of  smoking  and  family  history.
4
Because obesity accelerates the progression of
coronary atherosclerosis in young cohorts
5and
significant  cardiac  events  may  be  asympto-
matic,
6 early detection and treatment of those
with an increased BMI may yield significant
reductions  in  cardiovascular  morbidity  and
mortality.
Increased abdominal adiposity is associated
with the development of metabolic syndrome
7
which now affects over 47 million Americans.
8
In addition, an increased waist to hip ratio has
been  associated  with  a  heightened  risk  of
acute  myocardial  infarction.
9 Increased  BMI
imposes a pro- inflammatory state, releasing
factors such as high sensitivity-C reactive pro-
tein which is strongly associated with plaque
rupture  and  acute  cardiovascular  events.
4
Since traditional risk factors alone may under-
estimate  the  extent  of  subclinical  CAD  in
young cohorts,
10 a non-invasive imaging tech-
nique  to  accurately  assess  coronary  athero-
sclerosis may provide independent and addi-
tive information in risk stratifying this esca-
lating patient subset.   
Few data are available regarding the extent
and severity of CAD using coronary computed
tomographic angiography (CCTA) in morbidly
obese individuals. Previously, we have demon-
strated  that  using  a  novel  half-scan  recon-
struction  on  a  dual-source  CT  system  opti-
mizes image quality with acceptable signal-to-
noise and contrast-to-noise ratios which leads
to  diagnostic  images  in  >90%  of  morbidly
obese patients.
11 The present study was con-
ducted to describe coronary artery morphology
as  well  as  associated  obstructive  and  non-
obstructive  lesions,  risk  factors  and  demo-
graphics  in  patients  with  a  BMI  >40  kg/m
2
without known CAD. 
Materials and Methods
Study population
Morbidly obese subjects (BMI >40 kg/m
2)
were  prospectively  recruited  for  the  BMI-40
trial, using the outpatient facilities associated
with William Beaumont Hospital, Royal Oak,
Michigan, USA (Clinical Trials.gov Identifier:
NCT00468195).  Recruitment  advertisements
were  delivered  to  healthcare  providers  and
various  referral  centers  within  the  hospital
network. A total of 47 patients completed CCTA
on  a  dual-source  CT  scanner  (Somatom
Definition,  Siemens  Medical  Systems,
Forchheim, Germany). Image reconstructions
were performed with a standard quarter scan
mode (temporal resolution of 82 milliseconds)
and  image  quality  was  compared  to  images
reconstructed  using  a  novel  half-scan  mode
(temporal  resolution  of  165  milliseconds).
Diagnostic CCTA images were obtained using
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standardized  methodology  as  previously
described,  and  the  average  calculated  radia-
tion  exposure  for  each  patient  was  22±4.4
mSv.
11
Eligibility  criteria  for  inclusion  were:  (1)
BMI >40 kg/m
2; and (2) absence of pre-exist-
ing  CAD.  Those  with  an  iodinated  contrast
allergy, markedly irregular heart rhythm, preg-
nancy, renal insufficiency and inability to tol-
erate beta-blocking drugs were excluded from
study participation. The study was approved by
the  Human  Investigation  Committee  at
William  Beaumont  Hospital  and  all  patients
provided written informed consent. 
Data collection
Baseline  clinical  characteristics  included
age, sex, BMI, weight, waist and chest circum-
ference, hypertension, diabetes mellitus, ciga-
rette smoking, hyperlipidemia, use of lipid low-
ering medications, and a positive family histo-
ry of cardiovascular disease. 
Angiographic analyses and coronary
artery calcification measurement
CCTA was performed using a dual source CT
scanner  (Somatom  Definition,  Siemens
Medical Systems, Forchheim, Germany). CCTA
scans were analyzed according to previously
published  methodology
12 by  a  single  experi-
enced reader blinded to other findings (KC).
Image interpretation and calcium scoring was
performed  on  Somaris/7  Syngo  2007C
(Siemens  Medical  Systems,  Forchheim,
Germany)  and  an  offline  workstation
(Aquarius  3D  Workstation,  TeraRecon  Inc.,
San Mateo, CA, USA). Coronary artery calcium
(CAC) was measured using the Agatston scor-
ing method and reported in Hounsfield units
(HU).  Angiographic  analysis  was  performed
employing a previously described 17-segment
model of the coronary tree.
13 Lesions were clas-
sified by the maximal luminal diameter steno-
sis according to a qualitative severity scale: 0 =
no stenosis, 1 = 1% to 25%, 2 = 26% to 50%, 3
= 51% to 70%, 4 = 71% to 99%, 5 = total occlu-
sion.  Identified  atherosclerotic  plaques  were
classified as calcified or non-calcified. A calci-
fied plaque was defined as having ≥100 HU,
whereas, a non-calcified plaque had ≤99 HU.
Low-attenuation  plaques  were  identified  as
having ≤30 HU. For comparative purposes, the
study population was divided into two cohorts:
those with and without CAD. Coronary disease
was defined as the presence of any atheroscle-
rotic  lesion  (>1%  stenosis)  in  one  or  more
coronary  artery  segments.  Stenosis  was  fur-
ther  classified  as  mild  (1%-25%),  moderate
(26%-50%) and obstructive (>50%) in the pop-
ulation with CAD.
Statistical analysis
This  was  a  convenience  sample  and  no
power  calculations  were  formed.  Baseline
characteristics  were  expressed  as  mean  ±
standard deviation or counts with proportions
as  appropriate.  Statistical  analysis  was  per-
formed  using  Statistica  6.0  (StatSoft  Inc,
Oklahoma). All data were expressed as mean ±
standard  deviation  for  continuous  variables
and counts with proportions for dichotomous
variables.  Clinical  characteristics  in  the  two
groups  were  compared  using  2-sided  inde-
pendent-sample t-tests to detect statistical sig-
nificance. P<0.05 were considered significant.
Results
Patient characteristics
Of the 47 patients enrolled, 6 (12.8 %) were
excluded from the analysis because of incom-
plete  or  non-diagnostic  CCTA  studies.  Of  the
remaining 41 patients, 25 (61%) had CAD and
16 (39%) had normal coronary arteries. Baseline
characteristics of those patients with and with-
out CAD are shown in Table 1. In the CAD group,
history of diabetes, age and the prevalence of
hyperlipidemia were significantly greater. 
Coronary angiography
Of  the  total  study  population  (n=41),  25
patients  (61%)  had  at  least  one  coronary
stenosis  indicating  subclinical  CAD.  The
remaining 16 patients (39%) had normal coro-
nary arteries with no evidence of atheroscle-
rotic lesions. In the CAD group, 12 patients
(48%) had mild disease, 7 patients (28%) had
moderate disease and 6 patients (24%) had an
obstructive  coronary  artery  lesion.  Figure  1
shows the prevalence of CAD in this popula-
tion.  Of the 25 patients with CAD, 10 (40%) had
single vessel disease, 11 (44%) had double ves-
sel disease and 4 (16%) had triple vessel dis-
ease. Coronary stenoses involving the LAD were
present in 22 of the CAD patients (88%) and
observed in 8 (80%), 10 (45%) and 4 (31%)
Table 1. Patient characteristics.
Mean±SD (95% C.I.) Total CAD group  Non-CAD group P
Subjects N=41 N=25 N=16
Age (years) 50.4±10.0 52.8±9.4 46.7±10.1 0.054
(47.4-53.5) (49.2-56.5) (41.8-51.6)
BMI (kg/m
2)  43.8±4.8 43.8±4.9 43.6±4.7 0.889
(42.3-45.2) (41.9-45.7) (41.3-46.0)
Weight (lb) 272.4±46.9 274.8±52.9 268.6 ±36.9 0.682
(258.0-286.7) (254.1-295.5) (250.5-286.6)
Waist circumference (in.) 51.6±5.3 52.1±5.9 50.9±4.2 0.491
(50.0-53.3) (49.8-54.4) (48.9-53.0)
Chest circumference (in.) 51.8±4.5 51.9±4.5 51.6±4.5 0.800
(50.4-53.2) (50.2-53.7) (49.4-53.8)
Hypertension 33 (80%) 22 (88%) 11 (69%) 0.136
Diabetes mellitus 12 (29%) 11 (44%) 1 (6%) 0.009
Hyperlipidemia 23 (56%) 17 (68%) 6 (38%) 0.057
Lipid medications 15 (37%) 11 (44%) 4 (25%) 0.228
Cigarette smoking 16 (39%) 12 (48%) 4 (25%) 0.148
Male 13 (32%) 9 (36%) 4 (25%) 0.489
Family history 22 (54%) 14 (56%) 8 (50%) 0.715
Hypertension was defined as systolic blood pressure >140 mm Hg and/or a diastolic blood pressure >90 mm Hg, or treatment with antihyper-
tensive medications. Diabetes mellitus was defined as existing diagnosis of diabetes or current use of oral hypoglycemics or insulin therapy.
Hyperlipidemia was defined as a total cholesterol >200 mg/dL or current use of cholesterol lowering therapy. Family history of coronary dis-
ease was defined as reported history of coronary artery disease or of a myocardial infarction in a sibling or parent before the age of 55. BMI,
body mass index.
Figure 1. Prevalence of CAD among mor-
bidly obese subjects. Mild was defined as
1% to 25% stenosis. Moderate was defined
as 26% to 50% stenosis. Obstructive was
defined as >50% narrowing in any segment
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patients with 1, 2 and 3 vessel disease, respec-
tively. Of the 22 patients with LAD lesions, 11
(48%), 6 (30%) and 5 (22%) patients had mild,
moderate and obstructive disease, respectively.
Twelve patients had right coronary artery (RCA)
lesions; of these, 7 (58%), 4 (33%) and 1 (8%)
patient had mild, moderate and obstructive dis-
ease.  Of  the  7  patients  with  left  circumflex
artery (LCx) lesions, 3 had mild and 4 had mod-
erate disease. Lastly, only 4 patients had mild-
to-moderate  lesions  involving  the  left  main
(LM)  coronary  artery.  Figure  2  describes  the
location and degree of coronary lesions in the
LM, LAD, RCA and LCx within the CAD cohort.  
Plaque morphology 
In the cohort with CAD, 69 coronary plaques
were identified within the 425 coronary seg-
ments evaluated.  Of these lesions, 17 (24.6%)
were calcified and 52 (75.4%) were non-calci-
fied. Of the non-calcified plaques, 32 (61.5%)
were low- attenuation plaques. Ten (58.8%) of
the calcified plaques were found in the LAD, 6
(35.3%) were located in the RCA, and only 1
calcified plaque was identified in the LCx. Of
the  non-calcified  plaques,  31  (59.6%)  were
found in the LAD and most were low- attenua-
tion plaques. Non-calcified plaques were also
present in the RCA 10 (19.2%), LM 4 (7.7%)
and LCx 7 (13.5%), respectively.  Figure 3 illus-
trates a CCTA image of a non-calcified plaque
causing moderate stenosis at the ostium of the
LAD in a morbidly obese subject.
Coronary artery calcium
Coronary artery calcium was absent in all 16
patients  (39%)  without  CAD  and  2  patients
(5%)  with  CAD.  The  remaining  23  patients
(56%) with CAD all had coronary calcium >0.
Of the patients with CAD, 7 patients (28%) had
a CAC <10 HU, 9 (36%) had a CAC between 10
and 100 HU, 5 (20%) had a CAC between 101
and 400 HU and 4 (16%) had a CAC score >
than 400 HU. Overall, the artery with the high-
est  total  calcium  score  of  1311  HU  was  the
LAD. This was followed by the RCA, LCx and
LM with a total CAC score of 1142, 362 and 98
HU, respectively. Of the two patients with CAD
and a CAC=0, one had mild disease and the
other obstructive disease.  Six patients (86%)
with CAD and a CAC <10 HU had only mild
stenosis on CCTA. Among those patients with
CAC ranging between 10 and 100 HU, 5 (56%)
had mild stenosis and 3 (33%) had moderate
stenosis.  When  the  CAC  score  was  between
101 and 400 HU, an equal number of patients
had moderate disease (n=2; 40%) and obstruc-
tive disease (n=2; 40%). Lastly, when the CAC
score was >400 HU, 2 patients (50%) had mod-
erate  disease  and  2  patients  (50%)  had
obstructive disease. Figure 4 depicts the distri-
bution of CAD per CAC score. Increasing calci-
um  scores  were  associated  with  a  greater
prevalence  of  moderate  and  obstructive  dis-
ease in each coronary vessel.
Discussion  
Subclinical  atherosclerosis  is  common  in
the general population. The Framingham study
reported atherosclerosis in approximately one-
third of normal weight individuals; moreover,
40% of overweight participants and up to 50%
of obese individuals demonstrated subclinical
atherosclerotic  disease.
14 Our  data  extend
these  observations  in  that  61%  of  morbidly
obese  individuals  had  evidence  of  CAD  by
CCTA. 
Subclinical atherosclerosis has been shown
to predict the development of ischemic cardio-
vascular events.
15 Moreover, excess adiposity is
strongly related to acute coronary syndromes
occurring prematurely. A nationwide registry
of 111,847 patients with acute coronary syn-
dromes found that the first non-ST-elevation
myocardial infarction occurred, on average, 12
years earlier in patients with BMI >40 kg/m
2 as
compared with their normal weight counter-
parts. Multivariate analysis confirmed that a
BMI >40 kg/m
2 was more predictive of acute
myocardial infarction than any other variable
including  smoking  or  family  history.
4
Interestingly, the patients in the above study
who had a BMI >40 kg/m
2 were generally in
their fifties, as were the subjects in our study.  
Abdominal obesity and/or an elevated BMI
are associated with an increased prevalence of
CAC and progression of subclinical coronary
atherosclerosis.
16,17 In turn, the CAC burden is
widely considered to be a marker of atheroscle-
rosis and a risk factor for the development of
future  cardiac  events.
18 Specifically,  patients
with CAC of 1-100, 101-300 and >300 HU were
3.6, 7.73 and 9.67 times more likely to suffer
from  a  major  cardiac  event  compared  to
patients  with  a  CAC=0.
19 In  our  study,  most
patients  had  a  CAC  score  >0,  placing  this
young population at high risk.
Traditional risk factors such as family histo-
ry, diabetes mellitus, older age, cigarette smok-
ing,  hypercholesterolemia  and  hypertension
are harbingers for the development of CAC and
the  progression  of  atherosclerotic  heart  dis-
ease.
20 However, these risk factors alone may
be insufficient to identify subclinical disease
and patients at risk.
15 Detrano et al. reported
that CAC scoring strengthened the prediction
of  cardiac  events  when  used  in  conjunction
with these traditional risk factors.
19 Moreover,
recent  guidelines  recommend  screening
asymptomatic  patients  using  CAC  with  an
intermediate  risk  (between  10-20%,  10  year
estimated risk of coronary events) in order to
reclassify  patients  to  a  higher  risk  group.
21
Figure  2.  Distribution  and  severity  of
lesions in each coronary artery. Mild was
defined as 1% to 25% stenosis. Moderate
was  defined  as  26%  to  50%  stenosis.
Obstructive was defined as >50% narrow-
ing in any segment of the coronary artery
tree. CAD, coronary artery disease; LAD,
left anterior descending; LCx, left circum-
flex; LM, left main; RCA, right coronary
artery.
Figure 3. Non-calcified plaque identified in
the LAD. CCTA image of a non-calcified
plaque  causing  moderate  stenosis  at  the
ostium  of  the  LAD  in  a  morbidly  obese
subject. CCTA, coronary computed tomo-
graphic  angiography;  LAD,  left  anterior
descending.    
Figure 4. Severity of lesions according to
overall calcium score. Mild was defined as
1% to 25% stenosis. Moderate was defined
as 26% to 50% stenosis. Obstructive was
defined  as  >  50%  narrowing  in  any  seg-
ment  of  the  coronary  artery  tree.  CAC,
coronary  artery  calcium;  CAD,  coronary
artery disease.
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Given most of our patients with CAD had sev-
eral  risk  factors  and  a  CAC  >0,  they  could
potentially be reclassified to this higher risk
group leading to a more aggressive preventive
treatment regimen. 
Studies have also shown that asymptomatic
individuals with a CAC score of zero have a 10
year event rate of 1%, suggesting an excellent
survival.
22 However, these data are limited to
low risk asymptomatic individuals since recent
reports indicate that CAC scoring alone may
fail  to  reveal  obstructive  disease  in  sympto-
matic patients.
21 In our study, we observed one
patient with obstructive disease and another
with  mild  disease  on  CCTA  even  though
CAC=0. Therefore, in selected low risk asymp-
tomatic individuals CAC scoring may be used
to  rule  out  CAD  and  avoid  further  testing.
Accordingly, we essentially ruled out CAD in
one third of our subjects; however 2 patients
(8%) would have been missed using CAC scor-
ing alone. 
In a community based sample of 740 asymp-
tomatic  adults,  men  had  significantly  more
CAC than women in each arterial location.
23 In
women, the CAC was greatest in both the LAD
and RCA compared with the LCx. Among men,
the greatest CAC burden occurred in the LAD
followed by the RCA and LCx. In the present
study, we found a similar distribution of CAC
as detailed above; however, there was no sig-
nificant  difference  in  the  calcium  burden
between men and women. 
Hadamitzky  et  al.
24 studied  patients  with
suspected  CAD  using  CCTA  and  found  that
patients having obstructive lesions were three
times more likely to suffer from a severe car-
diac  event  compared  to  those  with  non-
obstructive disease (1.8% vs. 0.6%). Moreover,
Min and colleagues reported that predictors of
all-cause mortality were directly related to the
number of coronary plaques, severity of steno-
sis and the number of vessels involved, espe-
cially the LAD.
25 In contrast, patients with non-
obstructive disease had an overall survival of
99.7%. Given that 24% of patients with CAD in
our  study  had  obstructive  disease  and  most
had double or triple vessel disease affecting
the LAD, this may place the morbidly obese
population at increased risk for future cardiac
events.  
Coronary computed tomographic angiogra-
phy  may  also  be  used  in  conjunction  with
Framingham  risk  stratification  to  intensify
therapy to potentially prevent clinical disease.
Hadamitzky et al.
24 reported that the event rate
was significantly lower in patients with non-
obstructive disease and higher in obstructive
disease  compared  to  the  predicted
Framingham  risk  scores.  Although  CCTA  is
promising  and  currently  utilized  in  sympto-
matic  patients,  contemporary  guidelines  do
not  recommend  screening  asymptomatic
patients.
26
Diabetes has been shown to be significantly
related to an increased CAC burden in both
men and women. Moreover, previous studies
have shown that diabetes is an independent
risk factor for higher CAC scores as well as its
progression.
27 Using  CCTA,  Iwasaki  et  al.
reported increased coronary plaques and over-
all stenosis in asymptomatic diabetic patients
compared  with  their  non-diabetics  counter-
parts.
28 These observations are in agreement
with our findings.  However, since 11 patients
in  the  CAD  group  (44%)  had  diabetes  com-
pared to only 1 patient in the non-CAD group
(6%),  we  cannot  exclude  the  confounding
effect of diabetes on our patient population. 
Plaque morphology has also been proposed
as  an  important  determinant  of  subclinical
CAD
29 and a predictor of acute coronary syn-
dromes.
30 Hausleiter et al. observed that 29.8%
of  their  patient  population  (mean  BMI  26.3
kg/m
2, mean age 61 yrs, 14.8% diabetic) had
non-calcified plaques and that these subjects
had higher levels of total cholesterol, low-den-
sity lipoprotein and C-reactive protein levels.
29
Of those patients with CAD in our study, 75.4%
had non-calcified plaques and most had hyper-
lipidemia (68%) as well. Motoyama et al. stud-
ied the plaque composition of 1,059 subjects
who underwent CTA
30 and reported that low-
attenuation  non-calcified  plaques  (≤30  HU)
and  vascular  remodeling  were  predictors  of
acute  coronary  syndromes.  Although  we  did
not  calculate  a  remodeling  index,  we  noted
that almost half (46.5%) of the plaques identi-
fied in the CAD cohort were low-attenuation
and non-calcified. Identification of such low-
attenuation  non-calcified  plaques  may  place
this population at higher risk for future cardiac
events. Although this is an emerging feature of
CCTA, no consensus has been reached with
regards to plaque characterization using CCTA
since additional data are required.
26
To our knowledge, this is the first study to
describe the extent and severity of CAD using
CCTA in young morbidly obese individuals with
subclinical  disease.  Previous  CCTA  studies
have evaluated the extent of coronary stenosis
in non-obese patients
31 or in those with dia-
betes.
28 Choi  et  al. recruited  1,000  asympto-
matic  middle  aged  subjects  (BMI  24.1±2.7
kg/m
2,  age  50±9  yrs,  7.3%  diabetic,  14.1%
hyperlipidemia)  who  underwent  CCTA  as  a
general screening evaluation and reported that
215 patients (22%) had coronary plaques and
only 5% had obstructive disease.
31 Moreover,
most patients (73%) had single vessel disease
and  a  CAC=0  (82.5%).  Although  we  cannot
directly compare these findings with our own,
morbidly  obese  subjects  in  our  study  had
almost three times greater CAD identified, and
up to five times more obstructive disease. In
addition, most morbidly obese subjects in our
study had multi-vessel disease and a CAC>0.
However, our population had a higher preva-
lence of diabetes (29% vs. 7%).  
Although CTA is an attractive non-invasive
method for screening patients for subclinical
CAD,  it  cannot  be  recommended  until  stan-
dardized techniques for image acquisition are
defined  which  allow  an  acceptable  radiation
profile in this population. In the current study,
patients  received  a  relatively  high  radiation
dose (average 22±4.4 mSv) which may be an
underestimation,  given  recent  studies.
32
However, employing advanced scanning tech-
niques such as voltage modulation,
33 prospec-
tive gating
34 and volume scanning
32 the effec-
tive radiation dose can be potentially reduced
without  compromising  coronary  assessment
and diagnostic accuracy. Whether these tech-
niques will be applicable to the morbidly obese
population is still to be determined given that
increased weight is an independent factor for
increasing dose length product or DLP.
35
Study limitations
The primary limitations of this study are the
small  sample  size  and  the  lack  of  a  control
group of normal weight participants. Despite
the  high  accuracy  of  CCTA  in  both  normal
weight  and  moderately  obese  patients,  com-
parison of CCTA in morbidly obese individuals
with  conventional  coronary  angiography  is
required.  
Conclusions
The main finding of this preliminary study
was  that  CCTA  identified  61%  of  morbidly
obese patients as having CAD and most indi-
viduals had a CAC >0. Of the coronary seg-
ments studied, the LAD was the most common
artery affected, as well as the site of greatest
stenosis  and  CAC  burden.  Although  most
patients  had  non-  obstructive  CAD,  24%  of
these  patients  had  at  least  one  obstructive
coronary artery lesion. An increasing calcium
score also correlated with a greater severity of
disease in each coronary vessel.  Lastly, the
LAD contained the majority of both calcified
and non-calcified plaques, although the latter
predominated.   
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